Cite
Al-Shamasi AA, Elkaffash R, Mohamed M, et al. Crosstalk between Sodium-Glucose Cotransporter Inhibitors and Sodium-Hydrogen Exchanger 1 and 3 in Cardiometabolic Diseases. Int J Mol Sci. 2021;22(23)doi: 10.3390/ijms222312677.
Al-Shamasi, A. A., Elkaffash, R., Mohamed, M., Rayan, M., Al-Khater, D., Gadeau, A. P., Ahmed, R., Hasan, A., Eldassouki, H., Yalcin, H. C., Abdul-Ghani, M., & Mraiche, F. (2021). Crosstalk between Sodium-Glucose Cotransporter Inhibitors and Sodium-Hydrogen Exchanger 1 and 3 in Cardiometabolic Diseases. International journal of molecular sciences, 22(23), . https://doi.org/10.3390/ijms222312677
Al-Shamasi, Al-Anood, et al. "Crosstalk between Sodium-Glucose Cotransporter Inhibitors and Sodium-Hydrogen Exchanger 1 and 3 in Cardiometabolic Diseases." International journal of molecular sciences vol. 22,23 (2021). doi: https://doi.org/10.3390/ijms222312677
Al-Shamasi AA, Elkaffash R, Mohamed M, Rayan M, Al-Khater D, Gadeau AP, Ahmed R, Hasan A, Eldassouki H, Yalcin HC, Abdul-Ghani M, Mraiche F. Crosstalk between Sodium-Glucose Cotransporter Inhibitors and Sodium-Hydrogen Exchanger 1 and 3 in Cardiometabolic Diseases. Int J Mol Sci. 2021 Nov 24;22(23). doi: 10.3390/ijms222312677. PMID: 34884494; PMCID: PMC8657861.
Copy
Download .nbib